SEATTLE —
A Bristol-Myers Squibb finance executive was arrested Thursday on insider-trading charges involving three corporate deals including the company’s 2010 acquisition of ZymoGenetics.
The U.S. Attorney’s Office in New Jersey has charged Robert Ramnarine, BMS’s assistant treasurer for capital markets, with making about $311,361 in illegal profits from trades in ZymoGenetics, Pharmasset and Amylin Pharmaceuticals, according to court documents.
BMS announced an agreement to buy Seattle-based ZymoGenetics for about $885 million, or $9.75 per share, on Sept. 7, 2010.
According to a Federal Bureau of Investigation affidavit filed in federal court in New Jersey, Ramnarine learned in August about BMS’s plan to buy ZymoGenetics. Between Aug. 25 and 27 he bought options on Zymo stock through two brokerages accounts, selling the securities on Sept. 8 at a profit of more than $30,000, according to prosecutors.
The affidavit also details alleged insider trading in options of Pharmasset, which BMS considered buying but ultimately was acquired by Gilead Pharmaceuticals. While Ramnarine was tasked with conducting due diligence concerning BMS’s possible acquisition, according to the government, in November 2011 he purchased options that ultimately netted him more than $225,000 in profits.
Some options were purchased “from his office using his work-issued Blackberry,” says the FBI affidavit.
Ramnarine also is charged with making $55,784 in illegal profit from insider trading on information about BMS’s 47 billion acquisition of Amylin this past June.
Ramnarine has not yet entered a plea in the case.
Business
Drug executive charged over trading in ZymoGenetics
- Business
-
-
A late fade on Wall Street; Wal-Mart, Disney slump
Signs of a slowing economy combined with comments from a Federal Reserve official helped pull the stock market down Thursday.
-
American will favor passengers without roller bags
If you’re traveling light, you can board earlier on American Airlines.
-
Bill would limit lawsuits over lead contamination
A Missouri-based lead mining company could be shielded from punitive damages in state lead contamination lawsuits under a bill sent to Gov. Jay Nixon.
-
Senate panel considers labor board nominees
Senate Republicans said Thursday they would not support five nominees to the National Labor Relations Board, raising the possibility the troubled agency could be rendered mostly inoperable later this year.
-
Missouri lawmakers pass changes to workers’ comp claims
Missouri lawmakers gave final approval Thursday to a measure that would double the fees charged to businesses in order to replenish an insolvent fund for disabled workers who suffer serious job-related injuries or illnesses.
-
Work could begin soon on new Interstate 44 interchange east of Joplin
Construction of a new interchange at Interstate 44 and Prigmore Avenue to serve the Crossroads Center Business and Distribution Park was added Thursday to the Transportation Improvement Program for Southwest Missouri.
-
Dow to appeal $1.2 billion damages order
A federal judge is ordering Dow Chemical Co. to pay $1.21 billion in damages after it lost a class-action lawsuit that accused it of conspiring to fix prices.
-
Weak open on Wall Street; Wal-Mart disappoints
Wal-Mart led the Dow Jones industrial average lower early Thursday after the world’s largest retailer turned in weaker sales and a dim forecast for profits.
-
Tennessee senator: Sale idea cost TVA $500 million
Sen. Lamar Alexander says President Barack Obama’s plan to consider selling the Tennessee Valley Authority has already cost hundreds of millions of dollars — even if the nation’s largest public utility is never sold.
-
Google’s products dig deeper into people’s lives
For Google CEO Larry Page, happiness is a warm computer.
- More Business Headlines
-



